RecruitingPhase 2NCT07235046
A Study of DII235 in Adults With Elevated Lipoprotein(a)
Studying Disorder of lipid absorption and transport
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novartis Pharmaceuticals
- Principal Investigator
- Novartis PharmaceuticalsNovartis Pharmaceuticals
- Intervention
- DII235(drug)
- Enrollment
- 200 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2025 – 2028
Study locations (30)
- Parkway Medical Center, Birmingham, Alabama, United States
- Heart Center Research Llc, Huntsville, Alabama, United States
- Cardiology and Medicine Clinic PA, Little Rock, Arkansas, United States
- National Heart Institute, Beverly Hills, California, United States
- Alliance Clinical, Canoga Park, California, United States
- Excel Medical Clinical Trials LLC, Boca Raton, Florida, United States
- Zenith Clinical Research, Hollywood, Florida, United States
- Jacksonville Center for Clinical Research, Jacksonville, Florida, United States
- Flourish Res Acq LLC North Miami, Miami, Florida, United States
- Inpatient Research Clinical LLC, Miami Lakes, Florida, United States
- Ocala Cardiovascular Research, Ocala, Florida, United States
- SEC Clinical Research, Pensacola, Florida, United States
- Cardiology Partners Clinical Research Institute, Wellington, Florida, United States
- Atlanta Heart Specialists LLC, Tucker, Georgia, United States
- AMR Chicago, Oak Brook, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07235046 on ClinicalTrials.govOther trials for Disorder of lipid absorption and transport
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07327840Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)Kylonova (Xiamen) Biopharma co., LTD.
- ACTIVE NOT RECRUITINGPHASE2NCT07185776A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsFujian Shengdi Pharmaceutical Co., Ltd.
- RECRUITINGNCT07324902The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial DeformationUniversity of Athens
- ACTIVE NOT RECRUITINGNCT04156997Extreme Lipids RepositoryUniversity of Texas Southwestern Medical Center
See all trials for Disorder of lipid absorption and transport →